Trial Profile
Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Cepharanthine (Primary) ; Pilocarpine (Primary)
- Indications Sjogren's syndrome
- Focus Pharmacodynamics
- 07 Oct 2015 New trial record